T-TAS®01 – The Leading Edge in Platelet Thrombus Formation Assessment

Posted: June 1, 2022

It’s Not Just Support. It’s Solutions.

diapharma bioassays hemostasis thrombosis chromogenic

Innovative Total Platelet Function Analysis using Whole Blood

Global evaluation of overall hemostatic ability using physiologic, flow conditions

Exclusively from DiaPharma.

primary hemostasis assessment T-TAS 01

Advantages of T-TAS® 01 PL Assay

Ease of Interpretation

A numeric cut-off easily identifies those with primary hemostasis disorders, assisting with more timely determination of appropriate treatment strategy

Reduced Costs

May need fewer blood draws, as extra tests may be eliminated, improving the patient’s experience as well as eliminating the associated costs

Simple Pre-Analytics

Fewer blood draws without required fasting improves the patient’s (and phlebotomist’s) experience

Direct use of whole blood minimizes pre-analytical errors


Results in 10 minutes

Physiologically Relevant

T-TAS® 01 reconstructs in vivo blood flow conditions

For in vitro diagnostic use

Explore our full portfolio of hemostasis instruments and assays from DiaPharma

endothelial cell activation chromogenic assays, anticoagulation testing, ceveron, t-tas, atlas pst

*Research use only. Not for use in diagnostic procedures.


It’s Not Just Support. It’s Solutions.

Celebrating 25 years of scientific expertise,

with support just a call or click away.

diapharma bioassays hemostasis thrombosis chromogenic


Copyright © 2022 DiaPharma Group, Inc. All rights reserved.

DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069

Technical Support: 1.800.447.3846